Article
Sequence determinants of subtype-specific actions of KCNQ channel openers.
The Journal of physiology - 1 Feb 2017
Wang Alice W, Yang Runying, Kurata Harley T
Abstract excerpt
KEY POINTS: Retigabine is a KCNQ voltage-gated potassium channel opener that was recently approved as an add-on therapeutic for patients with drug-resistant epilepsy. Retigabine exhibits very little specificity between most KCNQ channel subtypes, and there is interest in generating more potent and specific KCNQ channel openers. The present study describes the marked specificity of ICA069673 for KCNQ2 vs. KCNQ3,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
